Agios Pharmaceuticals Inc... (AGIO)
NASDAQ: AGIO
· Real-Time Price · USD
34.41
-1.09 (-3.07%)
At close: Jun 20, 2025, 3:59 PM
34.42
0.03%
After-hours: Jun 20, 2025, 06:07 PM EDT
-3.07% (1D)
| Bid | 31 |
| Market Cap | 1.99B |
| Revenue (ttm) | 37.03M |
| Net Income (ttm) | 665.99M |
| EPS (ttm) | 11.54 |
| PE Ratio (ttm) | 2.98 |
| Forward PE | -5.35 |
| Analyst | Buy |
| Ask | 34.47 |
| Volume | 434,286 |
| Avg. Volume (20D) | 612,608 |
| Open | 35.55 |
| Previous Close | 35.50 |
| Day's Range | 33.90 - 35.70 |
| 52-Week Range | 23.42 - 62.58 |
| Beta | 0.73 |
About AGIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AGIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AGIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Agios Pharmaceuticals Inc. is scheduled to release its earnings on Jul 31, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
-4.04%
Agios Pharmaceuticals shares are trading lower aft...
Unlock content with
Pro Subscription
8 months ago
-5.08%
Agios Pharmaceuticals shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and cut its price target on the stock from $60 to $56.
1 month ago · seekingalpha.com
Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call TranscriptAgios Pharmaceuticals, Inc. (NASDAQ:AGIO ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants Chris Taylor – Vice President-Investor Relations and Corporate Communications Br...
